Genetic predictors of fatigue for prostate cancer patients receiving androgen deprivation therapy
Friday, October 26, 2012 - 14:40
in Health & Medicine
Researchers have found that men with prostate cancer who receive androgen deprivation therapy may predictably suffer from fatigue if they have single nucleotide polymorphisms in three pro-inflammatory genes. The discovery highlights the importance of personalized medicine, in which therapies are tailored to a patient’s genetic profile.